Akışa dön
74/100 Neutral 22.07.2026 · 01:17 Finrend AI ⏱ 1 dk 👁 3 TR

Trump Plans High Tariffs on Generic Drugs Starting in 2028

Former President Donald Trump is reportedly planning to impose high tariffs on generic drugs starting in 2028. This move aims to encourage pharmaceutical manufacturing in the United States. The plan includes a phased timeline and seeks to pressure generic drug manufacturers to relocate production facilities to the U.S. The tariffs are expected to have significant impacts on companies operating in the generic drug sector. The Trump administration's initiative is intended to strengthen the drug supply chain by boosting domestic production and reducing foreign dependency. According to the plan's details, the tariffs will take effect in 2028, giving manufacturers time to adjust. This policy change could lead to cost increases in the U.S. generic drug market. However, in the long term, prices may stabilize as domestic production rises. Trump's proposal aligns with goals of supply security and job creation in the pharmaceutical industry. This is not investment advice.

📊 ABBV — Piyasa Yorumu

▼ down · 60%

The news reports on Trump's plan to impose high customs tariffs on generic drugs. This could increase costs for pharmaceutical companies such as ABBV and negatively impact their profitability. Technical indicators show RSI at 60 and MACD below the signal line, signaling short-term weakness. Although the stock is above the 20-day moving average, the uncertainty created by the news may lead to selling pressure. Therefore, a downward movement is expected in the short term.

RSI 14
60.0
MACD
1.20
24h Δ
1.54%

📊 CVS — Piyasa Yorumu

▼ down · 70%

Trump's plan to impose high customs tariffs on generic drugs could increase global trade tensions and suppress risk appetite. This news may create short-term selling pressure, particularly in emerging markets and economies dependent on drug imports, such as Turkey. Markets may adopt a cautious stance amid concerns over renewed trade wars and cost inflation. However, the impact is likely to be limited, as the plan is spread over a long timeline, such as 2028.

RSI 14
MACD
24h Δ
0.00%
Canlı Grafikler

🔗 İlgili haberler

🧬 Buna benzer

AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.